Richard Pzena
Pzena Investment Management
Pzena Investment Management Portfolio 13F
Richard Pzena Holdings Activity
- Portfolio value:
- $25.70B≈ (+$1B≈)
- Previous value:
- $24.61B≈
- # of changes:
- 168
- New positions:
- 9
- Reported for:
- 30 Jun 2021 (Q2)
- Latest filing date:
- 06 Aug 2021
Pzena Investment Management has disclosed a total of 168 changes to the portfolio in the (2021 Q2) SEC report(s): increased the number of shares of 46, bought 9 totally new, decreased the number of shares of 99 and completely sold out 14 position(s).
What stocks did Richard Pzena buy in 2021 Q2?
During 2021 Q2 Richard Pzena has bought 55 securities out of which top 5 purchases (by % change to portfolio) were (HAL) Halliburton Company (added shares +7.48%), (AIG) American International Group Inc (added shares +3.09%), (WAB) Westinghouse Air Brake Technologies Corp (added shares +26.28%), (EIX) Edison International (added shares +10.73%) and (LEA) Lear Corp (added shares +3.76%).
What did Richard Pzena invest in during 2021 Q2?
In the 2021 Q2 report(s) the following changes have been made to the top investments: (GE) GE Aerospace (reduced shares -4.62%), (HAL) Halliburton Company (added shares +7.48%), (WFC) Wells Fargo & Company (reduced shares -3.97%), (AIG) American International Group Inc (added shares +3.09%) and (WAB) Westinghouse Air Brake Technologies Corp (added shares +26.28%).
168 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Huntington Bancshares Incorporated
|
new
|
+3,368,123
|
3,368,123
|
+0.19%
|
$14.27
|
+19.69%($17.08)
|
0.19%
|
2021 Q2
|
≈ 0.25 years
|
|
|
|
JAZZ PHARMACEUTICALS PLC
|
new
|
+1,546
|
1,546
|
+0%
|
$177.88
|
+42.45%($253.39)
|
0.00%
|
2021 Q2
|
≈ 0.25 years
|
|
|
|
Nokia Corp ADR
|
new
|
+16,255
|
16,255
|
+0%
|
$5.29
|
+72.95%($9.15)
|
0.00%
|
2021 Q2
|
≈ 0.25 years
|
|
|
|
PRA Health Sciences Inc
|
new
|
+3,378
|
3,378
|
+0%
|
$165.19
|
|
0.00%
|
2021 Q2
|
≈ 0.25 years
|
|
|
|
Everpure, Inc
|
new
|
+23,003
|
23,003
|
+0%
|
$19.52
|
+297.12%($77.52)
|
0.00%
|
2021 Q2
|
≈ 0.25 years
|
|
|
|
Qorvo Inc
|
new
|
+2,268
|
2,268
|
+0%
|
$195.77
|
-53.82%($90.40)
|
0.00%
|
2021 Q2
|
≈ 0.25 years
|
|
|
|
SS&C Technologies Holdings Inc
|
new
|
+6,572
|
6,572
|
+0%
|
$72.12
|
+5.72%($76.25)
|
0.00%
|
2021 Q2
|
≈ 0.25 years
|
|
|
|
United Therapeutics Corp
|
new
|
+2,296
|
2,296
|
+0%
|
$179.44
|
|
0.00%
|
2021 Q2
|
≈ 0.25 years
|
|
|
|
VTech Holdings Ltd ADR
|
new
|
+139,730
|
139,730
|
+0.01%
|
$10.43
|
|
0.01%
|
2021 Q2
|
≈ 0.25 years
|
|
|
|
Ambev SA ADR
|
+150.35%
|
+3,205,694
|
5,337,862
|
+0.04%
|
$3.44
|
-9.74%($3.10)
|
0.07%
|
2020 Q3
|
≈ 1.00 year
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.